Does Charles River Laboratories (CRL) have what it takes to be a top stock pick for momentum investors? Let's find out.
Have you evaluated the performance of Charles River Laboratories' (CRL) international operations during the quarter that concluded in September 2025? Considering the extensive worldwide presence of ...
Charles River Laboratories (CRL) reported $1.06 billion in revenue for the quarter ended June 2023, representing a year-over-year increase of 8.9%. EPS of $2.69 for the same period compares to $2.77 a ...
Charles River Laboratories International Inc CRL reported Q1 sales of $1.03 billion, an increase of 12.6% Y/Y, beating the consensus of $986.35 million. The company reported adjusted EPS of $2.78, ...
Detailed price information for Charles River Laboratories Intl (CRL-N) from The Globe and Mail including charting and trades.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results